JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Branda, L. A.
Right arrow Articles by du Vigneaud, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Branda, L. A.
Right arrow Articles by du Vigneaud, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Synthesis and Pharmacological Properties of Deamino-4-decarboxamido-oxytocin (1-ß-Mercaptopropionic Acid-4-agr-Aminobutyric Acid-Oxytocin)

Luis A. Branda 1, Stefania Drabarek 1, and Vincent du Vigneaud 1

From the 1 From the Department of Biochemistry, Cornell University Medical College, New York, New York 10021

Deamino-4-decarboxamido-oxytocin, an analogue of oxytocin in which the free amino group of the half-cystine residue at position 1 and the carboxamide group of the glutamine residue at position 4 have been replaced by hydrogen, has been synthesized. The protected polypeptide intermediate for this compound, prepared by the stepwise p-nitrophenyl ester method, was converted by the action of sodium in liquid ammonia into the disulfhydryl intermediate from which the analogue was obtained by oxidation with potassium ferricyanide. It was subsequently isolated either by countercurrent distribution or by partition chromatography on Sephadex, and was obtained in crystalline form from an aqueous solution.

Deamino-4-decarboxamido-oxytocin possesses approximately frac25 of the avian vasodepressor activity, frac16 of the oxytocic activity, and frac35 of the milk-ejecting activity of oxytocin. These potencies are considerably higher than the corresponding potencies of 4-decarboxamido-oxytocin. The deamino analogue has extremely low antidiuretic activity and no detectable pressor activity.

Submitted on January 26, 1966


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1966 by the American Society for Biochemistry and Molecular Biology.